As eating habits change on GLP-1 medications, magnesium intake may decrease, especially if you are consuming fewer whole foods
Semaglutide (Ozempic/Wegovy) dramatically improves fatty liver disease The good news keeps piling up for GLP-1 medications TL;DR: New clinical trial data shows semaglutide may reverse fatty (non-acoholic) liver disease
This correlated with an increase in the percentage of capillaries blocked in the core of the area at risk (12 mm deep in the left ventricular wall: Fig
Liraglutide, marketed under the brand names Victoza for diabetes management and Saxenda for weight management, is a versatile GLP-1 receptor agonist with a distinct focus on weight loss
In addition to the functional link between PKC and JNK, PKC also protects against APAP hepatotoxicity by a JNK-independent mechanism involving autophagy induction, as discussed below
The emerging role of lysosomes in copper homeostasis